PHI with Hanot's cirrhosis
How does this condition affect your private health insurance?
Hanot's syndrome, also known as primary biliary cholangitis (PBC), is a chronic autoimmune liver disease characterized by the progressive destruction of small bile ducts within the liver. This leads to cholestasis, where bile cannot flow out, causing toxic substances to accumulate. Over time, this results in inflammation, scarring (fibrosis), and eventually cirrhosis and liver failure. Common symptoms include severe fatigue and pruritus (itching). It predominantly affects middle-aged women. Diagnosis involves liver function tests, autoantibody detection (especially AMA), and sometimes liver biopsy. Treatment aims to slow disease progression.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms often develop insidiously over months to years before diagnosis; acute severe symptoms can manifest over weeks.
Duration of Illness (Lifetime)
Chronic, progressive disease lasting many years to decades, often requiring lifelong management.
Cost of Treatment (Initial)
Initial diagnostic workup and stabilization can range from several hundred to a few thousand USD.
Cost of Treatment (Lifetime)
Lifelong medication, regular monitoring, management of complications, and potential liver transplant lead to very high costs, potentially hundreds of thousands to over a million USD.
Mortality Rate
Without treatment, high probability of death due to liver failure. With early and consistent treatment, significantly improved survival, though still a risk.
Risk of Secondary Damages
High probability of severe fatigue, debilitating pruritus, osteoporosis, malabsorption, portal hypertension, variceal bleeding, ascites, and eventual liver failure.
Probability of Full Recovery
Very low; PBC is a chronic autoimmune disease with no known cure, treatment focuses on slowing progression.
Underlying Disease Risk
Moderate to high probability of co-occurring autoimmune diseases such as Sjögren's syndrome, autoimmune thyroiditis, and scleroderma.